FUNDAMENTALS · Fundamentals · KR Healthcare

Dong-A Socio Holdings (000640) Fundamentals 2026 — P/E 5.5x, Revenue Analysis | SniperIQ

Dong-A Socio Holdings (000640) is a KR-listed Healthcare company in Drug Manufacturers - Specialty & Generic with a market capitalization of ₩518.4B, trading at ₩77000.00 on the KSC. This SniperIQ fundamentals page covers Dong-A Socio Holdings's valuation (P/E 5.5x, P/B 0.4x), profitability (net margin 6.5%), revenue (₩1.43T in FY2025), balance-sheet quality, and AI signal context — from live market data, research only.

Market Cap₩518.4B
P/E (TTM)5.5x
Net Margin6.5%
Revenue (FY25)₩1.43T

Full research coverage

  • 8-Quarter Revenue & Margin Trend
  • Debt Maturity & Coverage
  • Peer Valuation Comparison
  • Free Cash Flow & Owner Earnings
  • AI Signal + Institutional Flow
  • DCF Valuation Model

Frequently Asked Questions

What is Dong-A Socio Holdings's market cap?

Dong-A Socio Holdings (000640) has a market capitalization of approximately ₩518.4B, trading at ₩77000.00 on the KSC. Market cap moves with the live share price.

What is Dong-A Socio Holdings's P/E ratio?

Dong-A Socio Holdings's trailing twelve-month P/E ratio is 5.5x, with a price-to-book (P/B) of 0.4x. Valuation multiples are best compared with Healthcare sector peers rather than read in isolation.

How profitable is Dong-A Socio Holdings?

Dong-A Socio Holdings runs a net profit margin of 6.5%, a gross margin of 31.2%, and an operating margin of 6.6%. Margins and ROE indicate how efficiently the business converts sales into profit and shareholder returns.

How much revenue does Dong-A Socio Holdings generate?

Dong-A Socio Holdings reported revenue of ₩1.43T for fiscal year 2025, with net income of ₩90.9B and earnings per share (EPS) of 13718. SniperIQ tracks the full 8-quarter revenue and margin trend on the research dashboard.

Does Dong-A Socio Holdings pay a dividend?

Dong-A Socio Holdings offers a trailing dividend yield of about 3.1%. Dividend sustainability depends on payout ratio, free cash flow, and earnings stability — all tracked in SniperIQ's fundamentals view.

Is Dong-A Socio Holdings financially healthy?

Dong-A Socio Holdings carries a debt-to-equity ratio of 0.57x and a current ratio of 0.79x, with a market beta of 0.08. Lower leverage and a current ratio above 1.0 generally signal a stronger balance sheet.

Is Dong-A Socio Holdings a good stock to buy in 2026?

SniperIQ provides research-only market intelligence, not personalised financial advice or a buy/sell call. For Dong-A Socio Holdings (000640) the key facts are: market cap ₩518.4B, P/E 5.5x, revenue ₩1.43T, 52-week range 74500-121844.664. Weigh valuation, profitability, growth, and balance-sheet strength against Healthcare peers and form your own view.

Track Dong-A Socio Holdings's full fundamentals live

Get Dong-A Socio Holdings's 8-quarter revenue and margin trend, peer comparison, DCF model, and AI signal on the SniperIQ research dashboard.

Related: Sugi Holdings (7649) fundamentals · Komipharm International (041960) fundamentals · Lunit (328130) fundamentals · COSMOS Pharmaceutical (3349) fundamentals · All stock fundamentals · AI signal library
Research Hubs: Fundamentals library · Screeners · Institutional positioning · Super investors · Daily signals · Platform comparisons